$3.86
-0.16[-3.98%]
At close: May 21
$3.86
0[0.00%]
After Hours: 6:50PM EDT
Autolus Therapeutics
(NASDAQ:AUTL)Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Open | $4.000 |
| Close | $3.870 |
| Volume / Avg. | 1.392M / 1.573M |
| Day Range | 3.860 - 4.200 |
| 52 Wk Range | 2.010 - 7.450 |
| Market Cap | $1.027B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 1.79% |
| Days to Cover | 1.58 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, May 17, 2024. The analyst firm set a price target for 9.00 expecting AUTL to rise to within 12 months (a possible 133.16% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $3.86 last updated May 21, 2024 at 6:50 PM EDT.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.